オキシプリノール
- 関
- alloxanthine
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/08/09 14:31:11」(JST)
[Wiki en表示]
Oxypurinol
|
Names |
Preferred IUPAC name
1,2-Dihydropyrazolo[4,3-e]pyrimidine-4,6-dione
|
Systematic IUPAC name
1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione
|
Other names
1H,2H,5H-pyrazolo[3,4-d]pyrimidine-4,6-dione
Alloxanthine
|
Identifiers |
CAS Registry Number
|
2465-59-0 |
Beilstein Reference
|
139956 |
ChEBI |
CHEBI:28315 |
ChEMBL |
ChEMBL859 Y |
ChemSpider |
4483 N |
EC number |
219-570-9 |
InChI
-
InChI=1S/C5H4N4O2/c10-4-2-1-6-9-3(2)7-5(11)8-4/h1H,(H3,6,7,8,9,10,11)
Key: HXNFUBHNUDHIGC-UHFFFAOYSA-N
|
Jmol-3D images |
Image |
KEGG |
C07599 |
MeSH |
Oxypurinol |
PubChem |
4644 |
|
UNII |
G97OZE5068 |
Properties |
Chemical formula
|
C5H4N4O2 |
Molar mass |
152.11086 |
Appearance |
white crystals |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Infobox references |
|
|
Oxypurinol is an inhibitor of xanthine oxidase. It is an active metabolite of allopurinol and it is cleared renally. In cases of renal disease, this metabolite will accumulate to toxic levels. By inhibiting xanthine oxidase, it reduces uric acid production. High serum uric acid levels may result in gout, kidney stones, and other medical conditions.
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
- Stamp LK1, Turner R1, Khalilova IS1, Zhang M1, Drake J1, Forbes LV1, Kettle AJ2.
- Rheumatology (Oxford, England).Rheumatology (Oxford).2014 Jun 4. pii: keu218. [Epub ahead of print]
- OBJECTIVES: The aims of this study were to establish whether, in patients with gout, MPO is released from neutrophils and urate is oxidized to allantoin and if these effects are attenuated by allopurinol.METHODS: MPO, urate, allantoin and oxypurinol were measured in plasma from 54 patients with gout
- PMID 24899662
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension.
- Montenegro MF, Pinheiro LC, Amaral JH, Ferreira GC, Portella RL, Tanus-Santos JE.
- Naunyn-Schmiedeberg's archives of pharmacology.Naunyn Schmiedebergs Arch Pharmacol.2014 Jun;387(6):591-8.
- Nitrate and nitrite have emerged as an important novel source of nitric oxide (NO). We have previously demonstrated that sodium nitrite is an antihypertensive compound that exerts antioxidant effects in experimental hypertension. These unpredicted antioxidant effects of nitrite raised the question w
- PMID 24658348
- Therapeutic drug monitoring in rheumatic diseases: utile or futile?
- Stamp LK, Barclay M.
- Rheumatology (Oxford, England).Rheumatology (Oxford).2014 Jun;53(6):988-97.
- Rapid and effective suppression of inflammation is a primary goal in the treatment of rheumatic diseases. However, the therapeutic effect of most medications may be slow to manifest, in the order of weeks or months in the case of DMARDs. Monitoring of drug concentrations allows the possibility of ap
- PMID 24196384
Japanese Journal
- Impairment by Hypoxia or Hypoxia/Reoxygenation of Nitric Oxide–Mediated Relaxation in Isolated Monkey Coronary Artery: the Role of Intracellular Superoxide
- Tawa Masashi,Yamamizu Kohei,Geddawy Ayman,Shimosato Takashi,Imamura Takeshi,Ayajiki Kazuhide,Okamura Tomio
- Journal of Pharmacological Sciences 116(2), 188-196, 2011
- … Under combined treatment of apocynin with oxypurinol (xanthine oxidase inhibitor), rotenone (mitochondria electron transport inhibitor), or both, hypoxic impairment of vasorelaxation was restored more effectively. … Similarly, impairment of the nitroglycerin-induced vasorelaxation under hypoxia/reoxygenation was restored by combined treatment with three inhibitors, apocynin, oxypurinol, and rotenone. …
- NAID 130000835863
- Measurement of urinary oxypurinol by high performance liquid chromatography-tandem mass spectrometry
- STOCKER Sophie L.,FRANKLIN Michael E.,ANDERSON Jacqueline M.,PILLANS Peter I.,WILLIAMS Kenneth M.,MCLACHLAN Andrew J.,DAY Richard O.,TAYLOR Paul J.
- Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878(25), 2363-2368, 2010-09-01
- NAID 10028040796
Related Links
- Sigma-Aldrich offers Sigma-O6881, Oxypurinol for your research needs. Find product specific information including CAS, MSDS, protocols and references. ... Biochem/physiol Actions An allopurinol metabolite.
- 1. Drugs R D. 2004;5(3):171-5. Oxipurinol: alloxanthine, Oxyprim, oxypurinol. [No authors listed] Oxipurinol [alloxanthine, Oxyprim, oxypurinol] is the active metabolite of the only commercially available xanthine oxidase inhibitor ...
Related Pictures
★リンクテーブル★
[★]
- 英
- oxypurinol
- 関
- アロキサンチン
-oxypurinol
[★]
アロキサンチン
- 関
- oxypurinol